Claire Deville

Claire Deville serves as a Radiochemist at the Hevesy Laboratory within the Department of Health Technology at the Technical University of Denmark (DTU) in Roskilde. Her research focuses on developing novel radiopharmaceuticals and delivery systems for cancer therapy and diagnostic applications.

Her primary research interests span radiochemistry, radionuclide production, and nanoparticle drug delivery systems. Deville specializes in cyclotron-based production of therapeutic isotopes like lanthanum-135 and erbium-165, with particular emphasis on Auger electron therapy applications. Her work bridges nuclear physics, materials science, and medical applications.

Analysis of her recent publications reveals strong thematic focus on improving radionuclide production efficiency and developing innovative delivery mechanisms, particularly gold nanoparticles for brain targeting via the glymphatic system. Her work demonstrates consistent collaboration with researchers like Jensen, Pedersen, and Søndergaard across multiple DTU departments.

Though no specific awards are listed in the available materials, her publications show significant impact with citation metrics including 22 citations for her glymphatic delivery work and multiple social media mentions.

Deville maintains active research collaborations both within DTU and internationally, as evidenced by her co-authorship on publications with researchers from various institutions. Her laboratory work appears centered on the Hevesy cyclotron facilities for radionuclide production and characterization.